PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Providers on Novel Strategies to Reduce Risk of HIV Acquisition
Expert faculty Jared Baeten, MD, PhD; Susan Buchbinder, MD; Connie L. Celum, MD, MPH; and Albert Liu, MD, MPH review emerging data on pre-exposure prophylaxis and antiretroviral therapy as prevention and discuss implications for community providers.

Advances in Preventing HIV Transmission Using Antiretroviral Therapy: The Role of OB/GYNs
In this downloadable slideset, Jean R. Anderson, MD, provides OB/GYNs, who are already familiar with the concept of antiretroviral therapy as prevention, with an an update of recent data that have demonstrated broader applications for the use of anti-HIV treatment as prevention.

Guidance on HIV Testing in Women
Download this quick-reference PDF for guidance on HIV testing and counseling in both pregnant and nonpregant women.

Guidance on the Use of Antiretroviral Therapy to Prevent Mother-to-Child HIV Transmission
Download this quick-reference PDF for guidance on recommended agents for use in pregnancy to prevent mother-to-child HIV transmission.

Guidance on Prevention of HIV Transmission in Serodiscordant Couples
Download this quick-reference PDF for guidance on the use of antiretroviral therapy in both the HIV-positive and HIV-negative persons in serodiscordant couples.

Keeping It Simple: Treatment Simplification in HIV Management
Santiago Moreno, MD, PhD, and Stefano Vella, MD, provide an in-depth, case-based review of key considerations and evidence-based strategies for simplifying HIV treatment.

Keeping It Simple: Treatment Simplification in HIV Management
Santiago Moreno, MD, PhD, and Stefano Vella, MD, provide an in-depth, case-based review of key considerations and evidence-based strategies for simplifying HIV treatment.

Starting Antiretroviral Therapy in 2012: A Compendium of Interactive Cases
Joseph J. Eron, Jr., MD, and Kathleen E. Squires, MD, challenge you to manage several patients who are candidates for first-line antiretroviral therapy. See if you make the same choices that they do!

Starting Antiretroviral Therapy in 2012
Expert faculty Joseph J. Eron, Jr., MD, and Kathleen E. Squires, MD, review considerations for first-line therapy and the considerations for tailoring therapy illustrated by a group of 6 patient cases.

Emerging Issues in First-line Antiretroviral Therapy
Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, review timing and choice of first-line antiretroviral therapy in this unique program with a didactic video module and several case-based vignettes in which you are invited to help manage the patient.

Emerging Issues in First-line Antiretroviral Therapy
Expert faculty Joel E. Gallant, MD, MPH, and Charles B. Hicks, MD, review considerations for first-line therapy and how emerging data are changing the landscape for treatment of naive patients.

HIV Highlights From Seattle
In this CME-certified slideset, Joseph J. Eron, Jr., MD, and Kimberly Y. Smith, MD, MPH, discuss the clinical implications of new data presented at the 2012 Conference on Retroviruses and Opportunistic Infections.

HIV Highlights From Seattle
Joseph J. Eron, Jr., MD, and Kimberly Y. Smith, MD, MPH, review the most clinically relevant studies presented at this important annual conference.

ICASA 2011 Conference Report
In this Conference Report, Meg C. Doherty, MD, MPH, PhD, and Jean B. Nachega, MD, PhD, discuss the clinical implications of key data presented at the 16th International Conference on AIDS and STIs in Africa.

Treatment Tradeoffs: Weighing the Benefits and Risks When Individualizing First-line Antiretroviral Therapy
José R. Arribas, MD, and Anton L. Pozniak, MD, FRCP, review the recommended/preferred and alternative options for initial therapy and discuss how the ideal regimen can be chosen for each patient by an individualized assessment of the advantages and disadvantages of each regimen.

Treatment Tradeoffs: Weighing the Benefits and Risks When Individualizing First-line Antiretroviral Therapy
Jose R. Arribas, MD, and Anton L. Pozniak, MD, FRCP, discuss the construction of individualized initial antiretroviral regimens based on “trading off” advantages and disadvantages of the agents in the regimen.

HIV/AIDS Highlights From Belgrade 2011
William G. Powderly, MD, and Peter Reiss, MD, PhD, review the most clinically relevant studies presented at this important biannual European conference.

• A Must Read: Real-World Outcomes of Antiretroviral Therapy in a Challenging Patient Population
  Kimberly Y. Smith, MD, MPH, and Andrew R. Zolopa, MD, discuss virologic suppression in a Baltimore city cohort and implications for real-world management of HIV.
• Case of the Month: Decision Making for the Initiation of HCV Treatment in an HIV-Coinfected Patient
  Susanna Naggie, MD, reviews a patient case involving an HIV/HCV-coinfected patient and discusses factors relevant for the initiation and choice of HCV therapy.
• Expert Viewpoint: Evolving Options for NNRTIs in Antiretroviral Regimens
  Kimberly Y. Smith, MD, MPH, and Joel E. Gallant, MD, MPH, discuss new guideline recommendations for the choice of NNRTIs in antiretroviral regimens

Audio, video, and slideset downloads are also provided for additional reference. Click here to start.

Preparing for PrEP: Answers for LGBT Community–Based Primary Care Practices on Emerging Strategies to Reduce Risk of HIV Acquisition
Review emerging data on pre-exposure prophylaxis and antiretroviral therapy as prevention with expert faculty Jared Baeten, MD, PhD; Susan Buchbinder, MD; Connie L. Celum, MD, MPH; and Albert Liu, MD, MPH.

From Podium to Practice: HIV Highlights From Chicago
In this CME-certified Conference Report, Joseph J. Eron, Jr., MD, and Joel E. Gallant, MD, MPH, discuss the clinical implications of key findings related to HIV-1 and hepatitis C virus infection presented at the 2011 Interscience Conference on Antimicrobial Agents and Chemotherapy.

HIV/AIDS Highlights From Chicago 2011
Join expert faculty members W. David Hardy, MD, and Kathleen E. Squires, MD, for a review of the HIV highlights of this important annual conference.

Direct-Acting Antivirals in Treatment-Naive HCV Patients
Mark S. Sulkowski, MD, reviews the latest data on and the approved indications of telaprevir and boceprevir in treatment-naive, genotype 1 HCV–infected patients.

Recent Advances in Antiretroviral Therapy
Joel E. Gallant, MD, MPH, reviews state-of-the-art management of antiretroviral therapy and discusses the clinical implication of recent data for HIV-infected patients.

HCV Resistance: Similarities and Differences With HIV 
Stuart Ray, MD, reviews key similarities and differences between the life cycles and resistance mechanisms of HCV and HIV and explores how these features may impact HCV treatment with newly approved direct-acting antiviral agents.

Healthcare Reform and HIV Care
Michael T. Wong, MD, discusses the healthcare reform measures of 2010 and potential impact on HIV treatment.

Direct-Acting Antivirals in Treatment-Experienced HCV Patients
Ira M. Jacobson, MD, reviews the key data and optimal use of protease inhibitor therapy in treatment-experienced individuals with HCV infection.

Management of Aging HIV-Infected Patients
Amy C. Justice, MD, MSc, PhD, discusses the aspects of HIV management affected by aging and describes use of the VACS Index, a tool that may be used to stratify risk in aging patients.

2011 HIV/Hepatitis C Annual Update
Download this slideset of selected key figures and tables from the CCO HIV and Hepatitis C Annual Update for use in your personal noncommercial presentations.

HIV/AIDS Highlights From Rome
In this downloadable slideset, Eric S. Daar, MD, and Joel E. Gallant, MD, MPH, review key studies from the 2011 International AIDS Society conference.

From Podium to Practice: Clinical Impact of New Data From IAS 2011
Review data from this important international meeting with expert faculty Anton L. Pozniak, MD, FRCP; Ian M. Sanne, MBBCH, FCP(SA); and Kimberly Y. Smith, MD, MPH, and see how they would apply this information to care of their HIV-infected patients.

IAS 2011 Conference Report: Clinical Studies in Resource-Limited Settings
Beatriz Grinsztejn, MD, PhD, and Jean Nachega, MD, PhD, discuss the challenges and forward momentum of HIV treatment in resource-limited settings, particularly sub-Saharan Africa.

The Evolving Role of Stavudine as Part of Initial Antiretroviral Therapy in Resource-Constrained Settings
Arnaldo David Casiró, MD, a local physician and clinical trial investigator in Buenos Aires, Argentina, discusses the current role of stavudine as part of first-line antiretroviral therapy in resource-limited settings as well as the barriers to modifying stavudine-containing regimens.

Answering the Questions: Implementing Routine HIV Testing in Primary Care Settings
In this CME/CE-certified learning module, C. Bradley Hare, MD; Donna Futterman, MD; and Alice C. Thornton, MD, AAHIVS, answer the most frequently asked questions on best strategies and key considerations for implementing routine HIV testing in clinical practice.

Faculty Responses to Additional Questions on Routine Testing for HIV Infection in Primary Care Settings 
In this CME/CE-certified learning module, C. Bradley Hare, MD; Donna Futterman, MD; and Alice C. Thornton, MD, AAHIVS, answer the most compelling questions posed by readers on the implementation of routine HIV testing in primary care settings.

Answering the Questions: Why and How to Implement Routine HIV Testing in Primary Care Settings
Program faculty Donna Futterman, MD, C. Bradley Hare, MD, and Alice C. Thornton, MD, AAHIVS, review data supporting early diagnosis of HIV and provide practical insight into implementing routine testing strategies into clinical practice.